Literature DB >> 14978678

Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight.

Frédéric Macia1, Caroline Perlemoine, Irène Coman, Dominique Guehl, Pierre Burbaud, Emmanuel Cuny, Henri Gin, Vincent Rigalleau, François Tison.   

Abstract

Weight, body mass index (BMI) and energy expenditure/energy intake (EE/EI) was studied in 19 Parkinson's disease (PD) patients after subthalamic deep brain stimulation (STN-DBS) versus 14 nonoperated ones. Operated patients had a significant weight gain (WG, + 9.7 +/- 7 kg) and BMI increase (+ 4.7 kg/m2). The fat mass was higher after STN-DBS. Resting EE (REE; offdrug/ON stimulation) was significantly decreased in STN-DBS patients, while their daily energy expenditure (DEI) was not significantly different. A significant correlation was found among WG, BMI increase, and pre-operative levodopa-equivalent daily dose, their reduction after STN-DBS, and the differential REE related to stimulation and the REE in the offdrug/OFF stimulation condition. In conclusion, STN-DBS in PD induces a significant WG associated with a reduction in REE without DEI adjustment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978678     DOI: 10.1002/mds.10630

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  29 in total

1.  Weight changes in subthalamic nucleus vs globus pallidus internus deep brain stimulation: results from the COMPARE Parkinson disease deep brain stimulation cohort.

Authors:  Maren C Locke; Samuel S Wu; Kelly D Foote; Marco Sassi; Charles E Jacobson; Ramon L Rodriguez; Hubert H Fernandez; Michael S Okun
Journal:  Neurosurgery       Date:  2011-05       Impact factor: 4.654

Review 2.  High frequency deep brain stimulation of the subthalamic nucleus versus continuous subcutaneous apomorphine infusion therapy: a review.

Authors:  R Carron; V Fraix; C Maineri; E Seigneuret; B Piallat; P Krack; P Pollak; A L Benabid; Stéphan Chabardès
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

3.  Body weight gain in patients with bilateral deep brain stimulation for dystonia.

Authors:  Marc E Wolf; Hans-Holger Capelle; Götz Lütjens; Anne D Ebert; Michael G Hennerici; Joachim K Krauss; Christian Blahak
Journal:  J Neural Transm (Vienna)       Date:  2015-08-22       Impact factor: 3.575

4.  Deep brain stimulation in Parkinson's disease.

Authors:  S J Groiss; L Wojtecki; M Südmeyer; A Schnitzler
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

Review 5.  What is the best treatment for fluctuating Parkinson's disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus?

Authors:  Rüdiger Hilker; Angelo Antonini; Per Odin
Journal:  J Neural Transm (Vienna)       Date:  2010-12-25       Impact factor: 3.575

6.  Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice.

Authors:  Paola Sgadò; Lavinia Albéri; Daniel Gherbassi; Sherri L Galasso; Geert M J Ramakers; Kambiz N Alavian; Marten P Smidt; Richard H Dyck; Horst H Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-02       Impact factor: 11.205

7.  Predictors of weight loss in early treated Parkinson's disease from the NET-PD LS-1 cohort.

Authors:  Anne-Marie Wills; Ruosha Li; Adriana Pérez; Xuehan Ren; James Boyd
Journal:  J Neurol       Date:  2017-07-15       Impact factor: 4.849

8.  Modulation of nutritional state in Parkinsonian patients with bilateral subthalamic nucleus stimulation.

Authors:  Joana Guimarães; Eduarda Matos; Maria José Rosas; Augusta Vieira-Coelho; Nuno Borges; Flora Correia; Rui Vaz; Carolina Garrett
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

9.  Weight gain after subthalamic nucleus deep brain stimulation in Parkinson's disease is influenced by dyskinesias' reduction and electrodes' position.

Authors:  Roberta Balestrino; Damiano Baroncini; Mario Fichera; Carmine Antonio Donofrio; Alberto Franzin; Pietro Mortini; Giancarlo Comi; Maria Antonietta Volontè
Journal:  Neurol Sci       Date:  2017-09-14       Impact factor: 3.307

10.  Influences of levodopa on adipose tissue and skeletal muscle metabolism in patients with idiopathic Parkinson's disease.

Authors:  Frauke Adams; Michael Boschmann; Elmar Lobsien; Andreas Kupsch; Axel Lipp; Gabriele Franke; Marie Charlotte Leisse; Juergen Janke; Simone Gottschalk; Joachim Spranger; Jens Jordan
Journal:  Eur J Clin Pharmacol       Date:  2008-07-30       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.